MBRX- Moleculin Biotech, Inc.

Over the past 90 days, insiders at Moleculin Biotech, Inc. (MBRX) have been net buyers, picking up 2,399,997 shares on balance.

Classified under Biotechnology (Health Care sector), MBRX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Klemp Walter V	2.55M	-	-
CFO	Foster Jonathan P.	1.42M	-	-
Other	Picker Donald H	789.6K	-	-
Dir	George Robert E.	165.3K	-	-
Dir	Cannon Michael D	165.3K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 3, 2026	Picker Donald H	Chief Science Officer	Buy	173,333	$0.00	-	+23,019%	-	-
Aug 3, 2026	Foster Jonathan P.	Chief Financial Officer	Buy	293,333	$0.00	-	+2,377%	-	-
Aug 3, 2026	Klemp Walter V	CEO And President	Buy	533,333	$0.00	-	+1,720%	-	-
Jun 23, 2025	Klemp Walter V	CEO And President	Buy	675,675	$0.37	$249,999.75	+994.6%	+49.0%	-59.8%
Jun 23, 2025	Foster Jonathan P.	Chief Financial Officer	Buy	270,270	$0.37	$99,999.90	+1,561%	+49.0%	-59.8%
Dec 26, 2023	George Robert E.	Director	Buy	14,493	$0.69	$10,000.17	+8,678%	-46.0%	-81.8%
Dec 26, 2023	Foster Jonathan P.	Chief Financial Officer	Buy	28,986	$0.69	$20,000.34	+56.2%	-46.0%	-81.8%
Dec 26, 2023	Klemp Walter V	CEO And President	Buy	188,404	$0.69	$129,998.76	+38.3%	-46.0%	-81.8%
Nov 25, 2022	Klemp Walter V	CEO And President	Buy	45,000	$1.28	$57,631.50	+12.3%	-3.9%	-56.5%
Nov 21, 2022	Klemp Walter V	CEO And President	Buy	22,500	$1.15	$25,866.00	+6.6%	+2.4%	-57.9%